News

PERNIX THERAPEUTICS REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS

MORRISTOWN, NJ, August 11, 2014 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter and year-to-date periods ended June 30, 2014. Business Update • “The second quarter of 2014 saw tremendous progress toward Pernix’s transformation to profitability...
Read more

PERNIX THERAPEUTICS APPOINTS CHIEF FINANCIAL OFFICER

Morristown, New Jersey, June 23, 2014 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced the appointment of Sanjay Patel as Chief Financial Officer. Mr. Patel brings to Pernix over 15 years of investment banking, institutional investment and public policy experience....
Read more